Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties.

Apolipoprotein E4 (apoE4) is a risk factor for Alzheimer's disease and has been associated with a variety of neuropathological processes. ApoE4 C-terminally truncated forms have been found in brains of Alzheimer's disease patients. Structural rearrangements in apoE4 are known to be key to its physiological functions. To understand the effect of C-terminal truncations on apoE4 lipid-free structure, we produced a series of recombinant apoE4 forms with progressive C-terminal deletions between residues 166 and 299. Circular dichroism measurements show a dramatic loss in helicity upon removal of the last 40 C-terminal residues, whereas further truncations of residues 203-259 lead to recovery of helical content. Further deletion of residues 186-202 leads to a small increase in helical content. Thermal denaturation indicated that removal of residues 260-299 leads to an increase in melting temperature but truncations down to residue 186 did not further affect the melting temperature. The progressive C-terminal truncations, however, gradually increased the cooperativity of thermal unfolding. Chemical denaturation of the apoE4 forms revealed a two-step process with a clear intermediate stage that is progressively lost as the C-terminus is truncated down to residue 230. Hydrophobic fluorescent probe binding suggested that regions 260-299 and 186-202 contain hydrophobic sites, the former being solvent accessible in the wild-type molecule and the latter being accessible only upon truncation. Taken together, our results show an important but complex role of apoE4 C-terminal segments in secondary structure stability and unfolding and suggest that interactions mediated by the C-terminal segments are important for the structural integrity and conformational changes of apoE4.

[1]  M. Nieminen,et al.  Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  H. Saito,et al.  Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms. , 2008, Biochemistry.

[3]  Radiya M. Sojitrawala,et al.  A monomeric, biologically active, full-length human apolipoprotein E. , 2007, Biochemistry.

[4]  K. Weisgraber,et al.  Apolipoprotein E•dipalmitoylphosphatidylcholine particles are ellipsoidal in solutions⃞ Published, JLR Papers in Press, February 17, 2007. , 2007, Journal of Lipid Research.

[5]  T. Forte,et al.  The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins. , 2007, Biochemistry.

[6]  K. Weisgraber,et al.  Apolipoprotein E structure: insights into function. , 2006, Trends in biochemical sciences.

[7]  R. Mahley,et al.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Saito,et al.  Effect of carboxyl-terminal truncation on structure and lipid interaction of human apolipoprotein E4. , 2006, Biochemistry.

[9]  K. Weisgraber,et al.  Model of Biologically Active Apolipoprotein E Bound to Dipalmitoylphosphatidylcholine* , 2006, Journal of Biological Chemistry.

[10]  R. Mahley,et al.  Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Krieger,et al.  SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux. , 2005, Biochemistry.

[12]  C. Adessi,et al.  A 13 kDa carboxy‐terminal fragment of ApoE stabilizes Abeta hexamers , 2005, Journal of neurochemistry.

[13]  Meir J Stampfer,et al.  Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease , 2004, Annals of Internal Medicine.

[14]  D. Kardassis,et al.  Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer , 2004, Current opinion in lipidology.

[15]  Tony Wyss-Coray,et al.  Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice , 2004, The Journal of Neuroscience.

[16]  K. Weisgraber,et al.  Effects of Polymorphism on the Lipid Interaction of Human Apolipoprotein E* , 2003, Journal of Biological Chemistry.

[17]  V. Zannis,et al.  Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain. , 2003, Biochemistry.

[18]  L. Mucke,et al.  Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Weisgraber,et al.  Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization DOI 10.1194/jlr.M200157-JLR200 , 2002, Journal of Lipid Research.

[20]  K. Weisgraber,et al.  Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism. , 2002, Biochimica et biophysica acta.

[21]  M. Krieger,et al.  Reconstituted Discoidal ApoE-Phospholipid Particles Are Ligands for the Scavenger Receptor BI , 2002, The Journal of Biological Chemistry.

[22]  R. Mahley,et al.  Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Weers,et al.  Modulation of the lipid binding properties of the N-terminal domain of human apolipoprotein E3. , 2001, European journal of biochemistry.

[24]  L. Havekes,et al.  The amino-terminal 1-185 domain of apoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for induction of hyperlipidemia in normal and apoE-deficient mice. , 2001, Biochemistry.

[25]  K. V. van Dijk,et al.  Domains of Apolipoprotein E Contributing to Triglyceride and Cholesterol Homeostasis in Vivo , 2001, The Journal of Biological Chemistry.

[26]  H. Brewer,et al.  Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. , 2001, Biochemical and biophysical research communications.

[27]  B. Rupp,et al.  Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. , 2000, Biochemistry.

[28]  J. Hoeg,et al.  Lipoproteins and atherogenesis. , 1998, Endocrinology and metabolism clinics of North America.

[29]  E. Matsubara,et al.  Isoform‐Specific Effects of Apolipoproteins E2, E3, and E4 on Cerebral Capillary Sequestration and Blood‐Brain Barrier Transport of Circulating Alzheimer's Amyloid β , 1997, Journal of neurochemistry.

[30]  D. Agard,et al.  Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. , 1994 .

[31]  D. Agard,et al.  Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein. , 1994, Structure.

[32]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[33]  D. Atkinson,et al.  Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism. , 1992, Biophysical journal.

[34]  G. Anantharamaiah,et al.  The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. , 1992, Journal of lipid research.

[35]  D A Agard,et al.  Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. , 1991, Science.

[36]  M. Krieger,et al.  Expression of ApoE gene in Chinese hamster cells with a reversible defect in O-glycosylation. Glycosylation is not required for apoE secretion. , 1989, The Journal of biological chemistry.

[37]  J. Taylor,et al.  Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. , 1989, The Journal of biological chemistry.

[38]  K. Weisgraber,et al.  Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. , 1988, The Journal of biological chemistry.

[39]  K. Weisgraber,et al.  Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. , 1988, The Journal of biological chemistry.

[40]  R J Havel,et al.  Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. , 1982, Journal of lipid research.

[41]  A. Gotto,et al.  Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. , 1973, Biochemistry.

[42]  G. Fasman,et al.  Computed circular dichroism spectra for the evaluation of protein conformation. , 1969, Biochemistry.

[43]  M. Shiao,et al.  Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution. , 2005, Biophysical journal.

[44]  K. Weisgraber,et al.  Apolipoprotein E4 Forms a Molten Globule A POTENTIAL BASIS FOR ITS ASSOCIATION WITH DISEASE* , 2002 .

[45]  J. Breslow,et al.  Human apolipoprotein E isoprotein subclasses are genetically determined. , 1981, American journal of human genetics.